ACADIA Pharmaceuticals Inc.
NASDAQACADIA Pharmaceuticals enters the week of its earnings release with short interest at a four-month high — up 25% in just one month — yet the borrow market remains so loose it barely registers as friction. The positioning shift is the story this week. Short interest has climbed steadily to 6.3% of the free float, adding more than 2.1 million shares since early April. The surge began…
Snapshot as of 7 May 2026
ACADIA Pharmaceuticals enters the week of its earnings release with short interest at a four-month high — up 25% in just one month — yet the borrow market remains so loose it barely registers as friction. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ACAD — free to start on ORTEX.
Sign up for free →Open ACAD on ORTEX